e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD – therapy/exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are there any significant differences in the bacterial carrier of acute exacerbation of severe and very severe COPD according the degree of pulmonary functional impairment?
L. M. Ristic, M. H. Rancic, M. A. Radovic, T. A. Pejcic, I. J. Stankovic (Nis, Serbia And Montenegro)
Source:
Annual Congress 2006 - COPD – therapy/exacerbations
Session:
COPD – therapy/exacerbations
Session type:
E-Posters in free access
Number:
298
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. M. Ristic, M. H. Rancic, M. A. Radovic, T. A. Pejcic, I. J. Stankovic (Nis, Serbia And Montenegro). Are there any significant differences in the bacterial carrier of acute exacerbation of severe and very severe COPD according the degree of pulmonary functional impairment?. Eur Respir J 2006; 28: Suppl. 50, 298
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
What are the differences between moderate and severe COPD exacerbation groups?
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Does inflammation decrease after recovery from severe exacerbation of COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Differences in vessel endothelium function in severe COPD and severe asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
The effectiveness of early pulmonary rehabilitation in acute exacerbation of COPD in the terms of functional and systemic markers.
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
Patients with mild to moderate asthma may develop clinically significant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Can seriousness of respiratory failure be predicted by the values of clinical score in patients with acute severe asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001
Both moderate and severe exacerbations accelerate physical activity decline in COPD patients
Source: Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017
Year: 2018
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Nutritional depletion and relationship to functional impairment in patients with chronic respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 677s
Year: 2004
Relationship between the severity of dyspnea and pulmonary function in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002
Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations
Source: Eur Respir J 2002; 20: Suppl. 38, 261s
Year: 2002
Muscle function and functional exercise capacity during and after a severe acute exacerbation of COPD.
Source: Virtual Congress 2020 – Physiotherapy in acute respiratory care
Year: 2020
The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Is a degree of asthma therapy related to pulmonary function impairment?
Source: Eur Respir J 2001; 18: Suppl. 33, 41s
Year: 2001
Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept